Literature DB >> 30865897

An Integrated Global Analysis of Compartmentalized HRAS Signaling.

Tapesh Santra1, Ana Herrero1, Javier Rodriguez1, Alex von Kriegsheim1, Luis F Iglesias-Martinez1, Thomas Schwarzl1, Des Higgins2, Thin-Thin Aye3, Albert J R Heck3, Fernando Calvo4, Lorena Agudo-Ibáñez4, Piero Crespo5, David Matallanas6, Walter Kolch7.   

Abstract

Modern omics technologies allow us to obtain global information on different types of biological networks. However, integrating these different types of analyses into a coherent framework for a comprehensive biological interpretation remains challenging. Here, we present a conceptual framework that integrates protein interaction, phosphoproteomics, and transcriptomics data. Applying this method to analyze HRAS signaling from different subcellular compartments shows that spatially defined networks contribute specific functions to HRAS signaling. Changes in HRAS protein interactions at different sites lead to different kinase activation patterns that differentially regulate gene transcription. HRAS-mediated signaling is the strongest from the cell membrane, but it regulates the largest number of genes from the endoplasmic reticulum. The integrated networks provide a topologically and functionally resolved view of HRAS signaling. They reveal distinct HRAS functions including the control of cell migration from the endoplasmic reticulum and TP53-dependent cell survival when signaling from the Golgi apparatus.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  RAS; TP53; apoptosis; cell migration; network biology; proteomics; signal transduction data integration; subcellular compartmentalization; transcriptomics

Mesh:

Substances:

Year:  2019        PMID: 30865897     DOI: 10.1016/j.celrep.2019.02.038

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  14 in total

1.  Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas.

Authors:  Mara Gilardi; Zhiyong Wang; Marco Proietto; Anastasia Chillà; Juan Luis Calleja-Valera; Yusuke Goto; Marco Vanoni; Matthew R Janes; Zbigniew Mikulski; Antonio Gualberto; Alfredo A Molinolo; Napoleone Ferrara; J Silvio Gutkind; Francis Burrows
Journal:  Mol Cancer Ther       Date:  2020-07-29       Impact factor: 6.261

Review 2.  Emerging RAS-directed therapies for cancer.

Authors:  Michael Conroy; Darren Cowzer; Walter Kolch; Austin G Duffy
Journal:  Cancer Drug Resist       Date:  2021-04-08

Review 3.  The Frequency of Ras Mutations in Cancer.

Authors:  Ian A Prior; Fiona E Hood; James L Hartley
Journal:  Cancer Res       Date:  2020-03-24       Impact factor: 12.701

Review 4.  A Comparative Analysis of Individual RAS Mutations in Cancer Biology.

Authors:  Carmen Muñoz-Maldonado; Yitzhak Zimmer; Michaela Medová
Journal:  Front Oncol       Date:  2019-10-18       Impact factor: 6.244

Review 5.  The Ins and Outs of RAS Effector Complexes.

Authors:  Christina Kiel; David Matallanas; Walter Kolch
Journal:  Biomolecules       Date:  2021-02-07

Review 6.  The Metabolic Landscape of RAS-Driven Cancers from biology to therapy.

Authors:  Suman Mukhopadhyay; Matthew G Vander Heiden; Frank McCormick
Journal:  Nat Cancer       Date:  2021-03-24

Review 7.  Palmitoylation as a Key Regulator of Ras Localization and Function.

Authors:  Carla Busquets-Hernández; Gemma Triola
Journal:  Front Mol Biosci       Date:  2021-03-17

8.  Using Multilayer Heterogeneous Networks to Infer Functions of Phosphorylated Sites.

Authors:  Joanne Watson; Jean-Marc Schwartz; Chiara Francavilla
Journal:  J Proteome Res       Date:  2021-06-24       Impact factor: 4.466

9.  All over the place: deciphering HRAS signaling from different subcellular compartments.

Authors:  Walter Kolch; David Matallanas
Journal:  Mol Cell Oncol       Date:  2019-05-20

10.  RAS Subcellular Localization Inversely Regulates Thyroid Tumor Growth and Dissemination.

Authors:  Yaiza García-Ibáñez; Garcilaso Riesco-Eizaguirre; Pilar Santisteban; Berta Casar; Piero Crespo
Journal:  Cancers (Basel)       Date:  2020-09-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.